Low-dose chlormadinone acetate for contraception. Clinical experience
Bergsjo, P.; Koller, O.
International Journal of Fertility 17(1): 35-42
1972
ISSN/ISBN: 0020-725X PMID: 4132146 Document Number: 46062
Document emailed within 1 workday
Related Documents
Gahr, M.; Freudenmann, R.W.; Connemann, B.J.; Kölle, M.A.; Schönfeldt-Lecuona, C. 2014: Rapid relapse in depression following initialization of oral contraception with ethinyl estradiol and chlormadinone acetate General Hospital Psychiatry 36(2): 230.E1Heskamp, M.-L.S.; Schramm, G.A.K. 2010: Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: physical and emotional benefits Contraception 81(1): 49-56
Kerscher, M.; Reuther, T.; Krueger, N.; Buntrock, H. 2013: Effects of an oral contraceptive containing chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal contraception Journal of the European Academy of Dermatology and Venereology: Jeadv 27(5): 601-608
Pelissier, C.; Basdevant, A.; Conard, J.; Egloff, M.; Husson, T.; Guyenne, T.T. 1987: Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study) Contraception Fertilite Sexualite 15(1): 45-54
Anthuber, S.; Schramm, G.A.K.; Heskamp, M.-L.S. 2010: Six-month evaluation of the benefits of the low-dose combined oral contraceptive chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg in young women: results of the prospective, observational, non-interventional, multicentre TeeNIS study Clinical Drug Investigation 30(4): 211-220
Uras, R.; Orrù, M.; Pani, F.; Marotto, M.F.; Pilloni, M.; Guerriero, S.; Etzi, R.; Zedda, P.; Sorge, R.; Lello, S.; Melis, G.B.; Paoletti, A.M. 2010: Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome Contraception 82(2): 131-138
Grandi, G.; Napolitano, A.; Xholli, A.; Tirelli, A.; Di Carlo, C.; Cagnacci, A. 2015: Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(10): 774-778
Meriggiola, M.C.; Bremner, W.J.; Costantino, A.; Di Cintio, G.; Flamigni, C. 1998: Low dose of cyproterone acetate and testosterone enanthate for contraception in men Human Reproduction 13(5): 1225-1229
Wildemeersch, D.; Schacht, E.; Wildemeersch, P.; Janssens, D.; Thiery, M. 2002: Development of a miniature, low-dose, frameless intrauterine levonorgestrel-releasing system for contraception and treatment: a review of initial clinical experience Reproductive Biomedicine Online 4(1): 71-82
Gómez Vázquez, M.; Navarra Amayuelas, R.ón.; Lamarca, M.; Baquedano, L.; Romero Ruiz, S.án.; Vilar-Checa, E.; Iniesta, M.D. 2011: Ethinylestradiol/Chlormadinone acetate for use in dermatological disorders American Journal of Clinical Dermatology 12(Suppl 1): 13-19
Guerra-Tapia, A.; Sancho Pérez, B. 2011: Ethinylestradiol/Chlormadinone acetate: dermatological benefits American Journal of Clinical Dermatology 12(Suppl 1): 3-11
Busch, W.; Hagelschuer, H.; Gränz, G.; Richter, G.; Werner, K. 1979: Hormonal desexing of boars with chlormadinone acetate Archiv für Experimentelle Veterinarmedizin 33(1): 99-109
Guerra-Tapia, A.; Sancho Pérez, B. 2011: Ethinylestradiol/Chlormadinone acetate: dermatological benefits American Journal of Clinical Dermatology 12(Suppl 1): 3-11
Jamin, C. 1992: Female contraception by a normal dose progestogen after 40 years of age. Possible association of nomegestrol--17-beta-estradiol acetate by percutaneous route Revue Francaise de Gynecologie et D'obstetrique 87(6): 370-376
Olivas Mendoza, G.; Santos Martínez, A.; Corral Olaguez, M.; Iduñate y Carlos, D.M.; Hernández Ayup, S. 1978: Dysfunctional uterine bleeding. Hormonal management with chlormadinone acetate Ginecologia y Obstetricia de Mexico 44(266): 463-471
Christie, G.A. 1969: Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive Medical Journal of Australia 2(4): 185-189
Schuffenhauer, W.; Lange, W. 1974: Functional cytology of bovine adenohypophysis and the effects of mestranol and chlormadinone acetate Archiv für Experimentelle Veterinarmedizin 28(5): 749-758
Tanaka, M.; Murai, M.; Tokunaga, H.; Kimura, T.; Okada, S. 1990: Chlormadinone Acetate Reference Standard (Control 881) of National Institute of Hygienic Sciences Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences 1990(108): 159-161
Caruso, S.; Rugolo, S.; Agnello, C.; Romano, M.; Cianci, A. 2009: Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate Journal of Sexual Medicine 6(12): 3376-3384
Gutiérrez-Nájar, A.; Márquez-Monter, H.; Giner-Velázquez, J.; Martínez-Manautou, J. 1968: Presence of corpus luteum as evidence of ovulation in women treated with low doses of chlormadinone acetate American Journal of Obstetrics and Gynecology 102(7): 1018-1022